Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Nga M. Do is active.

Publication


Featured researches published by Nga M. Do.


Tetrahedron Letters | 2000

A practical, efficient, and rapid method for the oxidation of electron deficient pyridines using trifluoroacetic anhydride and hydrogen peroxide–urea complex

Stephane Caron; Nga M. Do; Janice E. Sieser

Abstract A general method for the oxidation of electron-poor pyridines to their N-oxides using UHP and TFAA in either CH2Cl2 or CH3CN was developed. The methodology proved to tolerate a number of functional groups and substitution patterns and proceeded on notoriously difficult to oxidize substrates.


Analytical Chemistry | 2011

Application of Quantitative 19F and 1H NMR for Reaction Monitoring and In Situ Yield Determinations for an Early Stage Pharmaceutical Candidate

Nga M. Do; Mark Olivier; John J. Salisbury; Carrie B. Wager

Quantitative NMR spectrometry (qNMR) is an attractive, viable alternative to traditional chromatographic techniques. It is a fast, easy, accurate, and nondestructive technique which allows an analyst to gain quantitative information about a component mixture without the necessity of authentic reference materials, as is the case with most other analytical techniques. This is ideal for the synthesis of active pharmaceutical ingredients (API) that are in the early stages of development where authentic standards of the analytes may not be available. In this paper, the application of (19)F and (1)H qNMR for reaction monitoring and in situ potency determinations will be discussed for an early stage pharmaceutical candidate with several analytical challenges. These challenges include low UV absorption, low ionization, thermal instability, and lack of authentic reference standards. Quantitative NMR provided quick, fit-for-purpose solutions for process development where conventional separation techniques were limited.


Journal of Pharmaceutical and Biomedical Analysis | 2015

Method development and validation of arene substituted regioisomers in a pharmaceutical candidate by high temperature GC-FID.

John J. Salisbury; Nga M. Do; John A. Ragan

This paper describes the development and validation of a high temperature gas chromatography flame ionization detection (HTGC-FID) method for the purity evaluation of arene substituted regioisomers in a key starting material of a pharmaceutical candidate in Phase 3 studies. The chromatographic conditions of the method employ a (5%-phenyl)-methylpolysiloxane packed column (30m×0.25mm) at a constant flow of 1.0mLmin(-1) with a gradient temperature program from 150°C to 400°C with injector and detector temperatures of 300°C and 340°C, respectively. The calibration curve for the desired product (r=0.9999) was assessed for five points in the range from approximately 1.0μgmL(-1) to 40μgmL(-1). The precision (% RSD) of the method was calculated for six replicate injections and found to be 0.81%. The limits of detection and quantitation were determined to be 0.06 and 0.20μgmL(-1), respectively.


Synthesis | 2003

Alternative Biarylphosphines for Use in the Palladium-Catalyzed Amination of Aryl Halides

Robert A. Singer; Stephane Caron; Ruth E. McDermott; Patrice Arpin; Nga M. Do


Synthesis | 2003

Enantioselective Addition of a Trifluoromethyl Anion to Aryl Ketones and Aldehydes

Stephane Caron; Nga M. Do; Patrice Arpin; Alexandre Larivee


Organic Process Research & Development | 2007

Process Research and Development of an NK-1 Receptor Antagonist. Enantioselective Trifluoromethyl Addition to a Ketone in the Preparation of a Chiral Isochroman

Stephane Caron; Nga M. Do; Janice E. Sieser; Patrice Arpin; Enrique Vazquez


Organic Process Research & Development | 2014

Commercial Route Research and Development for SGLT2 Inhibitor Candidate Ertugliflozin

Paul Bowles; Steven J. Brenek; Stephane Caron; Nga M. Do; Michele T. Drexler; Shengquan Duan; Pascal Dubé; Eric C. Hansen; Brian P. Jones; Kris Nicole Jones; Tomislav A. Ljubicic; Teresa W. Makowski; Jason Mustakis; Jade D. Nelson; Mark Olivier; Zhihui Peng; Hahdi H. Perfect; David William Place; John A. Ragan; John J. Salisbury; Corey L. Stanchina; Brian C. Vanderplas; Mark E. Webster; R. Matt Weekly


Organic Process Research & Development | 2009

Development of a Practical and Efficient Synthesis of CP-945,598-01, a CB1 Antagonist for the Treatment of Obesity

John A. Ragan; Dennis E. Bourassa; Jon Blunt; Darragh Breen; Frank Robert Busch; Eric M. Cordi; David B. Damon; Nga M. Do; Alanya Engtrakul; Denis Lynch; Ruth E. McDermott; Joseph A. Mongillo; Maria M. O’Sullivan; Peter Robert Rose; Brian C. Vanderplas


Chimia | 2006

Process research and scale-up of the κ-opioid receptor agonist CJ-15,161 drug candidate

Brian M. Andresen; Stephane Caron; Michel Couturier; Keith Michael Devries; Nga M. Do; Kristina Dupont-Gaudet; Arun Ghosh; Melina Girardin; Joel M. Hawkins; Teresa Margaret Makowski; Maxime Riou; Janice E. Sieser; John L. Tucker; Brian C. Vanderplas; Timothy J. N. Watson


Archive | 2005

Novel benzyl(idene)-lactam derivatives

Michael Aaron Brodney; Stephane Caron; Christopher John Helal; Jeffrey W. Raggon; Yong Tao; Nga M. Do

Researchain Logo
Decentralizing Knowledge